Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Frontiers in Oncology|June 18, 2021
Tumor Genotyping and Homologous Recombination Repair Gene Variants in Patients With Epithelial Ovarian Cancer: Is Pathogenic Enough?Elena Fountzilas, Vassiliki Kotoula, Georgia-Angeliki Koliou, et al.
Plos One|September 30, 2016
Tumor Infiltrating Lymphocytes Affect the Outcome of Patients with Operable Triple-Negative Breast Cancer in Combination with Mutated Amino Acid ClassesVassiliki Kotoula, Sotiris Lakis, Ioannis S Vlachos, et al.
Cancer Research and Treatment|November 18, 2021
Clinical Significance of Major Angiogenesis-Related Effectors in Patients with Metastatic Breast Cancer Treated with Trastuzumab-Based RegimensHelen P Kourea, Foteinos-Ioannis Dimitrakopoulos, Georgia-Angeliki Koliou, et al.
Oncotarget|October 28, 2015
Tumors with high-density tumor infiltrating lymphocytes constitute a favorable entity in breast cancer: a pooled analysis of four prospective adjuvant trialsVassiliki Kotoula, Kyriakos Chatzopoulos, Sotiris Lakis, et al.
Clinical Colorectal Cancer|August 13, 2019
Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and BevacizumabGeorge Pentheroudakis, Leonidas Mavroeidis, Kyriaki Papadopoulou, et al.
Medical Oncology (Northwood, London, England)|June 2, 2018
Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotypingGeorge Papaxoinis, Vassiliki Kotoula, Eleni Giannoulatou, et al.
Oral Oncology|July 27, 2020
T cell fraction impacts oncologic outcomes in human papillomavirus associated oropharyngeal squamous cell carcinomaKathryn M Van Abel, David M Routman, Eric J Moore, et al.
Oncology Letters|December 6, 2021
mRNA expression of specific HER ligands and their association with clinical outcome in patients with metastatic breast cancer treated with trastuzumabVassiliki Rapti, Evangelia Moirogiorgou, Georgia-Angeliki Koliou, et al.
Cancer Immunology, Immunotherapy : CII|April 19, 2020
Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?Triantafyllia Koletsa, Vassiliki Kotoula, Georgia-Angeliki Koliou, et al.
Cancers|November 26, 2022
Association between CD8+ Tumor Infiltrating Lymphocytes and the Clinical Outcome of Patients with Operable Breast Cancer Treated with Adjuvant Dose-Dense Chemotherapy-A 10 Year Follow-Up Report of a Hellenic Cooperative Oncology Group Observational StudyNikolaos Spathas, Anna C Goussia, Georgia-Angeliki Koliou, et al.
Pageof 5